Vicore Pharma
在场
Vicore Pharma 是一家在股票代码 VICO (SE) 下上市的公司。
高管
查看带有其 20 名主要高管的组织结构图
Vicore Pharma 搜索最多的简介
高管在Vicore Pharma变化
- Ann Barbier已作为Director加入公司 (新闻发布的2024五月14号).
- Yasir Al-Wakeel已作为Director加入公司 (新闻发布的2024五月14号).
- Hans Schikan 曾任 Director, 现升职为 Chairman of the Board (新闻发布的2024五月8号).
创建提醒
跟踪 Vicore Pharma 的高管变动
药店
Vicore Pharma 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Vicore Pharma 的最新新闻稿
- Increase in number of shares and votes in Vicore Pharma - Vicore Pharma
- Vicore announces the Nomination Committee for the 2025 Annual General Meeting - Vicore Pharma
- Vicore Pharma raises approximately SEK 782 million through an oversubscribed rights issue - Vicore Pharma
- Vicore Pharma has successfully carried out a directed share issue of approximately SEK 100 million - Vicore Pharma
- Vicore Pharma publishes preliminary outcome in the rights issue - Vicore Pharma
- Vicore Announces Investment from Sanofi - Vicore Pharma
- Vicore Announces Additional Subscription Undertaking from HealthCap - Vicore Pharma
- Vicore Publishes Prospectus Relating to the Rights Issue - Vicore Pharma
- Vicore Initiates the Global, Randomized Phase 2b ASPIRE Trial Evaluating the Disease-Modifying Potential of Buloxibutid in Idiopathic Pulmonary Fibrosis - Vicore Pharma
- Vicore Pharma announces a rights issue of approximately SEK 782 million - Vicore Pharma
- View more press releases Close
通过电子邮件
